Xanodyne Pharmaceuticals, Inc. · Newport, KY United States
Company Description
Xanodyne Pharmaceuticals hopes that its medicines can be the X factor needed to treat ailments. The company develops and manufactures drugs for pain management and women's health. Its commercial offerings include pain treatments Darvocet, Roxicodone, and Oramorph SR, as well as Duet prenatal vitamins. Xanodyne has several drugs in late-stage development, including Zipsor, a treatment for mild to moderate inflammatory pain such as arthritic pain. Other candidates include a treatment for menorrhagia (excessive menstrual bleeding). The company funds its development efforts through sales of its commercial products, which are marketed through an internal sales force. To read the full description, subscribe now.
Key Xanodyne Pharmaceuticals, Inc. Financials
| Company Type | Private Headquarters |
| Fiscal Year-End | December |
| Employees | 125 |
Xanodyne Pharmaceuticals, Inc. Executives
| Title | Name & Bio | Contact |
| Chairman | Rolf Classon | Network |
| President, CEO, and Director | Michael Valentino | Network |
| CFO and CIO | Rita O'Connor | Network |
